NNNN
Anbio Biotechnology
4.05
+0.25 (+6.58%)
52w low 3.09
44.73 high
2.3% of range
Financial Analysis
| Ratio | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross Margin | -- | 53.4% | 50.1% | 71.9% | 87.2% | |
| Operating Margin | -- | 43.3% | 29.2% | 24.4% | 66.7% | |
| EBITDA Margin | -- | 42.6% | 29.4% | 24.4% | 66.7% | |
| Net Margin | -- | 42.5% | 33.6% | 29.0% | 74.1% | |
| FCF Margin | -- | 18.9% | 13.4% | 25.4% | -77.9% | |
| Returns | ||||||
| Return on Equity | -- | 79.8% | 15.2% | 13.8% | 21.2% | |
| Return on Assets | -- | 71.7% | 14.3% | 12.5% | 21.2% | |
| Return on Inv Capital | -- | 79.9% | 13.2% | 11.6% | 19.1% | |
| Liquidity | ||||||
| Current Ratio | -- | 9.88x | 15.86x | 10.71x | 344.31x | |
| Quick Ratio | -- | 9.63x | 15.86x | 10.71x | 344.31x | |
| Cash Ratio | -- | 5.03x | 9.76x | 6.80x | 88.42x | |
| Leverage | ||||||
| Interest Coverage | -- | 1252.55x | -- | -- | -- | |
| Equity Multiplier | -- | 1.11x | 1.07x | 1.10x | 1.00x | |
| Efficiency | ||||||
| Asset Turnover | -- | 1.69x | 0.42x | 0.43x | 0.29x | |
| Inventory Turnover | -- | 31.03x | -- | -- | -- | |
| Effective Tax Rate | -- | 0.0% | 0.0% | 0.0% | 0.0% | |
| Op CF / Net Income | -- | 0.44x | 0.40x | 0.88x | -1.05x | |
| Investment | ||||||
| R&D / Revenue | -- | 0.8% | 2.0% | 5.5% | 2.3% | |
| SG&A / Revenue | -- | 9.2% | 18.9% | 42.0% | 18.2% | |
Revenue CAGR
-28.4%
Net Income CAGR
-13.8%
EPS CAGR
+28.7%
FCF CAGR
--
Revenue YoY
+5.6%